Bicycle Therapeutics (BCYC) Assets Average (2019 - 2026)
Bicycle Therapeutics (BCYC) posted Assets Average of $685.0 million for Q1 2026, down 7.53% on a QoQ basis from $740.8 million in Q4 2025, and down 25.57% year-over-year from $920.4 million in Q1 2025.
Bicycle Therapeutics (BCYC) Assets Average (2019 - 2026) Analysis & Trends
Bicycle Therapeutics' Assets Average history runs 8 years deep, the most recent figure standing at $685.0 million for Q1 2026.
- Quarterly Assets Average fell 25.57% year-over-year to $685.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $685.0 million (down 25.57% YoY) and the FY2025 annual result came in at $837.2 million, up 7.88% from the prior year.
- Assets Average was $685.0 million for Q1 2026 at Bicycle Therapeutics, down from $740.8 million in the prior quarter.
- Across five years, Assets Average topped out at $1.0 billion in Q3 2024 and bottomed at $413.9 million in Q4 2022.
- A 5-year average of $657.2 million and a median of $617.0 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average jumped 143.99% — and 2026, when it slipped 25.57%.
- Bicycle Therapeutics' Assets Average stood at $413.9 million in 2022, then soared by 49.08% to $617.0 million in 2023, then soared by 58.31% to $976.8 million in 2024, then slipped by 24.16% to $740.8 million in 2025, then retreated by 7.53% to $685.0 million in 2026.
- Business Quant data shows BCYC's Assets Average at $685.0 million in Q1 2026, $740.8 million in Q4 2025, and $798.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | 685.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 685.00 Mn |
| Dec 31, 2025 | 740.78 Mn |
| Sep 30, 2025 | 798.07 Mn |
| Jun 30, 2025 | 858.04 Mn |
| Mar 31, 2025 | 920.38 Mn |
| Dec 31, 2024 | 976.81 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 802.25 Mn |
| Mar 31, 2024 | 571.24 Mn |
| Dec 31, 2023 | 617.01 Mn |
| Sep 30, 2023 | 546.43 Mn |
| Jun 30, 2023 | 441.49 Mn |
| Mar 31, 2023 | 419.71 Mn |
| Dec 31, 2022 | 413.88 Mn |
| Sep 30, 2022 | 431.32 Mn |
| Jun 30, 2022 | 452.52 Mn |
| Mar 31, 2022 | 469.68 Mn |
| Dec 31, 2021 | 380.56 Mn |
| Sep 30, 2021 | 253.69 Mn |
| Jun 30, 2021 | 224.95 Mn |